Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BANDERA, Alessandra")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresolBULGHERONI, Elisabetta; BANDERA, Alessandra; GALLI, Massimo et al.AIDS research and human retroviruses. 2005, Vol 21, Num 9, pp 815-819, issn 0889-2229, 5 p.Article

Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignanciesBANDERA, Alessandra; VERGA, Luisa; PERSEGHIN, Paolo et al.AIDS (London). 2013, Vol 27, Num 6, pp 1037-1039, issn 0269-9370, 3 p.Article

Low-dose prolonged intermittent interleukin-2 adjuvant therapy: Results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairmentMARCHETTI, Giulia; MERONI, Luca; GALLI, Massimo et al.The Journal of infectious diseases. 2002, Vol 186, Num 5, pp 606-616, issn 0022-1899, 11 p.Article

Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamicsMARCHETTI, Giulia; MERONI, Luca; MOLTENI, Chiara et al.AIDS (London). 2004, Vol 18, Num 2, pp 211-216, issn 0269-9370, 6 p.Article

PCR-hybridization assay for Mycobacterium avium complex : Optimization of detection in peripheral blood from humansFERRARIO, Giulio; GORI, Andrea; ROSSI, Agostino et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 4, pp 1638-1643, issn 0095-1137Article

Unmasking tuberculosis in the era of antiretroviral treatmentLAPADULA, Giuseppe; SORIA, Alessandro; BANDERA, Alessandra et al.The European respiratory journal. 2012, Vol 39, Num 5, pp 1064-1075, issn 0903-1936, 12 p.Article

Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot phase I/II trialGORI, Andrea; TRABATTONI, Daria; GALLI, Massimo et al.Antiviral therapy (London). 2004, Vol 9, Num 4, pp 603-614, issn 1359-6535, 12 p.Article

Under Representation of the Inhibitory KIR3DL1 Molecule and the KIR3DL1+/BW4+ Complex in HIV Exposed Seronegative IndividualsROSA GUERINI, Franca; LO CAPUTO, Sergio; GORI, Andrea et al.The Journal of infectious diseases. 2011, Vol 203, Num 9, pp 1235-1239, issn 0022-1899, 5 p.Article

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapyPICONI, Stefania; TRABATTONI, Daria; GORI, Andrea et al.AIDS (London). 2010, Vol 24, Num 13, pp 1991-2000, issn 0269-9370, 10 p.Article

Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut―associated lymphoid tissue induced by acute HIV infectionTINCATI, Camilla; BIASIN, Mara; CLERICI, Mario et al.Antiviral therapy (London). 2009, Vol 14, Num 3, pp 321-330, issn 1359-6535, 10 p.Article

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosisBANDERA, Alessandra; GORI, Andrea; FRANZETTI, Fabio et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 6, pp 2213-2218, issn 0095-1137Article

  • Page / 1